ADD-What impact do Revlimid® (lenalidomide) and Pomalyst® (pomalidomide) have on the bone marrow?

In this weeks video, Brian G.M. Durie explains that even though Revlimid and Pomalyst may reduce white blood cell counts, they do not permanently affect the bone marrow.

BOTTOM LINE:
Revlimid and Pomalyst may reduce white blood cell counts, so stop or adjust dosing accordingly.